Why the study?
Inferior vena cava tumor thrombus occurs in 4%-10% of renal cell carcinoma cases, and robotic-assisted radical nephrectomy with thrombectomy offers a minimally invasive alternative to open surgery.
Does robotic-assisted radical nephrectomy with IVC thrombectomy provide a safe and feasible approach in patients with RCC and IVC tumor thrombus?
Does robotic-assisted radical nephrectomy with IVC thrombectomy provide a safe and feasible approach in patients with RCC and IVC tumor thrombus?
Robotic-assisted radical nephrectomy with IVC thrombectomy is a feasible and safe procedure for patients with RCC and IVC tumor thrombus, resulting in minimal blood loss and no serious complications.
INTRODUCTION: Inferior vena cava (IVC) tumor thrombus occurs in 4%-10% of renal cell carcinoma (RCC) cases. Robotic-assisted radical nephrectomy (RARN) with IVC tumor thrombectomy offers a minimally invasive alternative to open surgery. MATERIALS AND METHODS: We retrospectively reviewed six cases of RARN for RCC with IVC thrombus at two institutions between April 2022 and August 2024. For left-sided RCC, the left renal vein was transected using a vascular stapler before IVC thrombectomy, ensuring adequate access for thrombus removal. RESULTS: Four patients had right-sided RCC, and two had left-sided RCC. The median operative time was 256 min, with a median blood loss of 175 mL. No conversions to open surgery, positive surgical margins, or major complications (Clavien-Dindo grade ≥ 3) were reported. No blood transfusions were required. CONCLUSION: RARN with IVC thrombectomy resulted in minimal blood loss and no serious complications. Our findings suggest that it is a feasible and safe procedure, even when performed with technical modifications for left-sided RCC.
No takes yet. Share an insight, caveat, or question.
Hara et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: